PADI2 and post-transplant lymphoproliferative disease: Given that age positively correlated with anti-PAD2 antibodies, we performed a case-control study with 30 individuals with PTLD who had the lowest scores on the PLQS (<5) and 30 individuals with the highest neurological scores (≥17) matched for age, sex, and disease duration.